Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCG
- 5 November 1971
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 174 (4009) , 591-593
- https://doi.org/10.1126/science.174.4009.591
Abstract
Firmly established methylcholanthrene fibrosarcomas in syngeneic mice will totally disappear if the hosts are treated with living tumor cells that have been exposed to Vibrio cholerae neuraminidase in vitro. The effect is magnified by the simultanieous injection of a nonspecific immunostimulant, BCG. The rejection of the methylcholanthrene tumor is immunospecific and can be induced only with tumor cells, treated with Vibrio cholerae neuraminidase, identical in type with the growing tumor.Keywords
This publication has 16 references indexed in Scilit:
- Further Studies on the Effect of Neuraminidase on Tumor Cell TransplantabilityTissue Antigens, 1971
- ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLSThe Journal of Experimental Medicine, 1971
- Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovisScience, 1971
- Regulation of antigenic expressionJournal of Theoretical Biology, 1970
- Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with NeuraminidaseNature, 1968
- AN ALTERATION IN TUMOR HISTOCOMPATIBILITY INDUCED BY NEURAMINIDASETransplantation, 1967
- THE MASKING OF ANTIGENS ON TROPHOBLAST AND CANCER CELLSThe Lancet, 1967
- Differences in splitting capacity of virus and V. cholerae neuraminidases on sialic acid type substratesBiochemical and Biophysical Research Communications, 1967
- Electrophoretic behaviour of cellsProgress in Biophysics and Molecular Biology, 1966
- STUDIES ON CELL DEFORMABILITYThe Journal of cell biology, 1965